Work

CANOPY-A: A phase III study of canakinumab as adjuvant therapy in patients with surgically resected non-small cell lung cancer (NSCLC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.tps8570

Authors: Edward B. Garon, Andrea Ardizzoni, Fabrice Barlesi, Byoung Chul Cho, Pedro De Marchi, Yasushi Goto, Shun Lu, Luis G. Paz-Ares, David R. Spigel, Michael Thomas, Bijoyesh Mookerjee, Pilar Cazorla Arratia, Jason Baum, Yi-Yang Yvonne Lau, Zewen Zhu, James Chih-Hsin Yang

Institutions: University of California, Los Angeles, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Aix-Marseille Université, Yonsei University, Hospital de Câncer de Barretos, National Cancer Center Hospital, Shanghai Jiao Tong University, Shanghai Chest Hospital, Hospital Universitario 12 De Octubre, Sarah Cannon, Heidelberg University, University Hospital Heidelberg, German Center for Lung Research, Novartis (United States), National Taiwan University

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947657887

Cites:

Cited by: 8

Related to: 10